How much did Veradigm achieve in EBIT for the current year?
In the current year, Veradigm has achieved an EBIT of 85.74 M USD.
Veradigm EBIT 2024
Veradigm EBIT
85.74 M USD
Ticker
MDRX
ISIN
US01988P1084
WKN
607917
In 2024, Veradigm's EBIT was 85.74 M USD, a -12.78% increase from the 98.31 M USD EBIT recorded in the previous year.
The Veradigm EBIT history
| YEAR | EBIT (undefined USD) |
|---|---|
| 2028e | 181.66 |
| 2027e | 141.78 |
| 2026e | 241.03 |
| 2025e | 222.05 |
| 2024e | 85.74 |
| 2023e | 98.31 |
| 2022e | 133.31 |
| 2021 | 89 |
| 2020 | -56 |
| 2019 | -63.1 |
| 2018 | -96.7 |
| 2017 | 12.5 |
| 2016 | 72.4 |
| 2015 | 33.4 |
| 2014 | -36.8 |
| 2013 | -100.1 |
| 2012 | 24.4 |
| 2011 | 136.5 |
| 2010 | 104.6 |
| 2009 | 45.9 |
| 2008 | 40.2 |
| 2007 | 28.1 |
| 2006 | 19.9 |
| 2005 | 9.2 |
| 2004 | 3.2 |
| 2003 | -6.3 |
| 2002 | -17.1 |
Veradigm Revenue, EBIT, Net Income US01988P1084 · 607917
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Veradigm, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Veradigm from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Veradigm’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Veradigm. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Veradigm’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Veradigm’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Veradigm’s growth potential.
Veradigm Revenue, EBIT and net profit per share
| Date | Veradigm Revenue | Veradigm EBIT | Veradigm Net Income |
|---|---|---|---|
| 2028e | 864.76 M undefined | 181.66 M undefined | 157 M undefined |
| 2027e | 788.26 M undefined | 141.78 M undefined | 118.58 M undefined |
| 2026e | 822.17 M undefined | 241.03 M undefined | 59.57 M undefined |
| 2025e | 781.52 M undefined | 222.05 M undefined | 128.03 M undefined |
| 2024e | 654.15 M undefined | 85.74 M undefined | 73.56 M undefined |
| 2023e | 634.73 M undefined | 98.31 M undefined | 94.42 M undefined |
| 2022e | 626.35 M undefined | 133.31 M undefined | 89.3 M undefined |
| 2021 | 1.5 B undefined | 89 M undefined | 134.4 M undefined |
| 2020 | 1.5 B undefined | -56 M undefined | 700.4 M undefined |
| 2019 | 1.63 B undefined | -63.1 M undefined | -182.2 M undefined |
| 2018 | 1.62 B undefined | -96.7 M undefined | 363.7 M undefined |
| 2017 | 1.5 B undefined | 12.5 M undefined | -196.5 M undefined |
| 2016 | 1.39 B undefined | 72.4 M undefined | -25.7 M undefined |
| 2015 | 1.39 B undefined | 33.4 M undefined | -2.2 M undefined |
| 2014 | 1.38 B undefined | -36.8 M undefined | -66.5 M undefined |
| 2013 | 1.37 B undefined | -100.1 M undefined | -104 M undefined |
| 2012 | 1.45 B undefined | 24.4 M undefined | -1.2 M undefined |
| 2011 | 1.44 B undefined | 136.5 M undefined | 73.6 M undefined |
| 2010 | 704.5 M undefined | 104.6 M undefined | 61.6 M undefined |
| 2009 | 548.4 M undefined | 45.9 M undefined | 25.6 M undefined |
| 2008 | 383.8 M undefined | 40.2 M undefined | 25.4 M undefined |
| 2007 | 281.9 M undefined | 28.1 M undefined | 20.6 M undefined |
| 2006 | 228 M undefined | 19.9 M undefined | 11.9 M undefined |
| 2005 | 120.6 M undefined | 9.2 M undefined | 9.7 M undefined |
| 2004 | 100.8 M undefined | 3.2 M undefined | 3.1 M undefined |
| 2003 | 85.8 M undefined | -6.3 M undefined | -5 M undefined |
| 2002 | 78.8 M undefined | -17.1 M undefined | -15.2 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2002 | 78.8 M USD | -17.1 M USD | -15.2 M USD |
| 2003 | 85.8 M USD | -6.3 M USD | -5 M USD |
| 2004 | 100.8 M USD | 3.2 M USD | 3.1 M USD |
| 2005 | 120.6 M USD | 9.2 M USD | 9.7 M USD |
| 2006 | 228 M USD | 19.9 M USD | 11.9 M USD |
| 2007 | 281.9 M USD | 28.1 M USD | 20.6 M USD |
| 2008 | 383.8 M USD | 40.2 M USD | 25.4 M USD |
| 2009 | 548.4 M USD | 45.9 M USD | 25.6 M USD |
| 2010 | 704.5 M USD | 104.6 M USD | 61.6 M USD |
| 2011 | 1.44 B USD | 136.5 M USD | 73.6 M USD |
| 2012 | 1.45 B USD | 24.4 M USD | -1.2 M USD |
| 2013 | 1.37 B USD | -100.1 M USD | -104 M USD |
| 2014 | 1.38 B USD | -36.8 M USD | -66.5 M USD |
| 2015 | 1.39 B USD | 33.4 M USD | -2.2 M USD |
| 2016 | 1.39 B USD | 72.4 M USD | -25.7 M USD |
| 2017 | 1.5 B USD | 12.5 M USD | -196.5 M USD |
| 2018 | 1.62 B USD | -96.7 M USD | 363.7 M USD |
| 2019 | 1.63 B USD | -63.1 M USD | -182.2 M USD |
| 2020 | 1.5 B USD | -56 M USD | 700.4 M USD |
| 2021 | 1.5 B USD | 89 M USD | 134.4 M USD |
| 2022e | 626.35 M USD | 133.31 M USD | 89.3 M USD |
| 2023e | 634.73 M USD | 98.31 M USD | 94.42 M USD |
| 2024e | 654.15 M USD | 85.74 M USD | 73.56 M USD |
| 2025e | 781.52 M USD | 222.05 M USD | 128.03 M USD |
| 2026e | 822.17 M USD | 241.03 M USD | 59.57 M USD |
| 2027e | 788.26 M USD | 141.78 M USD | 118.58 M USD |
| 2028e | 864.76 M USD | 181.66 M USD | 157 M USD |
Veradigm stock margins US01988P1084 · 607917
The Veradigm margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Veradigm. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Veradigm.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Veradigm's sales revenue. A higher gross margin percentage indicates that the Veradigm retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Veradigm's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Veradigm's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Veradigm's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Veradigm. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Veradigm's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Veradigm Margin History
| Veradigm Gross margin | Veradigm Profit margin | Veradigm EBIT margin | Veradigm Profit margin |
|---|---|---|---|
| 2028e | 41.22 % | 21.01 % | 18.16 % |
| 2027e | 41.22 % | 17.99 % | 15.04 % |
| 2026e | 41.22 % | 29.32 % | 7.25 % |
| 2025e | 41.22 % | 28.41 % | 16.38 % |
| 2024e | 41.22 % | 13.11 % | 11.25 % |
| 2023e | 41.22 % | 15.49 % | 14.88 % |
| 2022e | 41.22 % | 21.28 % | 14.26 % |
| 2021 | 41.22 % | 5.92 % | 8.94 % |
| 2020 | 37.65 % | -3.73 % | 46.61 % |
| 2019 | 37.38 % | -3.87 % | -11.16 % |
| 2018 | 38.41 % | -5.98 % | 22.48 % |
| 2017 | 42.25 % | 0.83 % | -13.12 % |
| 2016 | 43.38 % | 5.22 % | -1.85 % |
| 2015 | 41.88 % | 2.41 % | -0.16 % |
| 2014 | 39.63 % | -2.67 % | -4.83 % |
| 2013 | 38.93 % | -7.29 % | -7.57 % |
| 2012 | 41.93 % | 1.69 % | -0.08 % |
| 2011 | 46.09 % | 9.45 % | 5.1 % |
| 2010 | 55.19 % | 14.85 % | 8.74 % |
| 2009 | 53.28 % | 8.37 % | 4.67 % |
| 2008 | 53.91 % | 10.47 % | 6.62 % |
| 2007 | 49.8 % | 9.97 % | 7.31 % |
| 2006 | 50.83 % | 8.73 % | 5.22 % |
| 2005 | 45.52 % | 7.63 % | 8.04 % |
| 2004 | 42.26 % | 3.17 % | 3.08 % |
| 2003 | 35.78 % | -7.34 % | -5.83 % |
| 2002 | 25.25 % | -21.7 % | -19.29 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2002 | 25.25 % | -21.7 % | -19.29 % |
| 2003 | 35.78 % | -7.34 % | -5.83 % |
| 2004 | 42.26 % | 3.17 % | 3.08 % |
| 2005 | 45.52 % | 7.63 % | 8.04 % |
| 2006 | 50.83 % | 8.73 % | 5.22 % |
| 2007 | 49.8 % | 9.97 % | 7.31 % |
| 2008 | 53.91 % | 10.47 % | 6.62 % |
| 2009 | 53.28 % | 8.37 % | 4.67 % |
| 2010 | 55.19 % | 14.85 % | 8.74 % |
| 2011 | 46.09 % | 9.45 % | 5.1 % |
| 2012 | 41.93 % | 1.69 % | -0.08 % |
| 2013 | 38.93 % | -7.29 % | -7.57 % |
| 2014 | 39.63 % | -2.67 % | -4.83 % |
| 2015 | 41.88 % | 2.41 % | -0.16 % |
| 2016 | 43.38 % | 5.22 % | -1.85 % |
| 2017 | 42.25 % | 0.83 % | -13.12 % |
| 2018 | 38.41 % | -5.98 % | 22.48 % |
| 2019 | 37.38 % | -3.87 % | -11.16 % |
| 2020 | 37.65 % | -3.73 % | 46.61 % |
| 2021 | 41.22 % | 5.92 % | 8.94 % |
| 2022e | 41.22 % | 21.28 % | 14.26 % |
| 2023e | 41.22 % | 15.49 % | 14.88 % |
| 2024e | 41.22 % | 13.11 % | 11.25 % |
| 2025e | 41.22 % | 28.41 % | 16.38 % |
| 2026e | 41.22 % | 29.32 % | 7.25 % |
| 2027e | 41.22 % | 17.99 % | 15.04 % |
| 2028e | 41.22 % | 21.01 % | 18.16 % |
Veradigm Aktienanalyse
What does Veradigm do?
Allscripts Healthcare Solutions Inc is one of the leading companies in the digital healthcare sector in the USA. The company was founded in 1982 and has since become one of the most important providers of IT solutions in healthcare. Allscripts supports healthcare providers in improving patient care and efficiency through the development and provision of innovative software and IT solutions. The business model of Allscripts is based on the development and sale of web-based software solutions for medical documentation and hospital management. These solutions are mainly distributed to hospitals and practices through subscriptions or licenses. Allscripts offers a variety of products that focus on various areas of medical care. One of the main divisions of the company is the electronic health records system (EHR). This system allows for the electronic recording, storage, and management of medical data and information. This enables healthcare providers to quickly and easily access patient information and document important diagnoses and treatments. Another important division of Allscripts is the Revenue Cycle Management (RCM), which optimizes billing and payment processes in hospitals and practices. In addition, Allscripts also offers solutions for telemedicine, including patient portal applications, remote patient monitoring systems, and mobile apps for patients and providers. Allscripts is based in Chicago and employs over 10,000 employees in various countries. The company also maintains partnerships with other companies in healthcare to facilitate and improve the complexity of digital transformation in the healthcare market. This includes companies like Microsoft, who work together with Allscripts on the development of artificial intelligence for healthcare applications. Allscripts' portfolio of offerings is very broad and provides customers with a variety of software solutions for different areas of medical care. The products are particularly characterized by their user-friendly interfaces, flexibility, and scalability. This allows customers to customize the solutions to their specific needs and consider future requirements. However, some products have been criticized for their expandability, poor design, and slow loading times. Recently, Allscripts has made a number of investments in research and development to address these issues and optimize the applications. In summary, Allscripts Healthcare Solutions Inc is considered one of the leading providers of software and IT solutions in healthcare in the USA. Thanks to a wide range of products and close collaboration with partners in healthcare, Allscripts is able to offer its customers innovative and scalable solutions that help them optimize their business processes and improve the quality of their medical care. Veradigm ist eines der beliebtesten Unternehmen auf Eulerpool.com.EBIT Details
Analyzing Veradigm's EBIT
Veradigm's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.
Year-to-Year Comparison
A yearly comparison of Veradigm's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.
Impact on Investments
Veradigm's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.
Interpreting EBIT Fluctuations
Fluctuations in Veradigm’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.
Frequently Asked Questions about Veradigm stock
What is EBIT?
EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Veradigm.
How has the EBIT of Veradigm developed in recent years?
The EBIT of Veradigm has increased by -12.785% decreased compared to the previous year.
What does EBIT mean for investors?
EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.
Why is EBIT an important indicator for investors?
Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.
Why do EBIT values fluctuate?
EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.
What role does tax burden play in EBIT?
Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.
How is EBIT presented in the balance sheet of the company Veradigm?
The EBIT of Veradigm is listed in the income statement.
Can EBIT be used as a single indicator for evaluating a company?
EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.
Why is EBIT not equal to net profit?
The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.
How much dividend does Veradigm pay?
Over the past 12 months, Veradigm paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Veradigm is expected to pay a dividend of 0 USD.
What is the dividend yield of Veradigm?
The current dividend yield of Veradigm is .
When does Veradigm pay dividends?
Veradigm pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Veradigm?
Veradigm paid dividends every year for the past 0 years.
What is the dividend of Veradigm?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Veradigm located?
Veradigm is assigned to the 'Health' sector.
Wann musste ich die Aktien von Veradigm kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Veradigm from 8/9/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/9/2024.
When did Veradigm pay the last dividend?
The last dividend was paid out on 8/9/2024.
What was the dividend of Veradigm in the year 2023?
In the year 2023, Veradigm distributed 0 USD as dividends.
In which currency does Veradigm pay out the dividend?
The dividends of Veradigm are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Veradigm
Our stock analysis for Veradigm Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Veradigm Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
